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Purpose: The objective of our cross-sectional study is to explore the adherence behavior of 
patients with type 2 diabetes mellitus (T2DM) by examining the association between the various 
types of adherence. The success of diabetic therapy partly relies on patient motivation, psych-
odemographic variables (self-efficacy, health literacy, and health locus of control [HLOC]), 
and adherence. The aim of our research was to explore the attitudes of T2DM patients toward 
medication and lifestyle therapy, thus gaining a deeper insight into the role of adherence-
determining parameters in disease management.
Patients and methods: The sample for the present study consisted of 113 T2DM inpatients 
(75 women and 38 men) with a mean age of 60.56 years (SD=12.94, range: 20–85 years) diag-
nosed with T2DM for an average of 13 years (SD=8.23). Participants completed the Diabetes 
Adherence Questionnaire conceptualized by the research team in accordance with the mapping 
of psychological and psychosocial parameters. We examined the associations between vari-
ables using Spearman’s rank correlation. Multivariate regression analysis was used to examine 
predictive variables for adherent behavior. In addition, we attempted to examine factors with 
a negative effect on adherence using factor analysis.
Results: Based on our results, a high level of medication adherence negatively correlated with 
lifestyle adherence. Multivariate regression analysis showed that blood glucose monitoring 
adherence is mostly predicted by social–external HLOC, diabetes self-efficacy, and internal 
HLOC, while dietary adherence is predicted by the patient’s self-efficacy and duration of the 
illness. Additionally, understanding and following the diabetes treatment were significantly 
associated with dietary adherence and high levels of patient self-efficacy, while health literacy 
was mostly predicted by internal HLOC.
Conclusion: Adherence to medication, diet, glucose monitoring, and physical exercise showed 
different levels in T2DM patients and were in association with psychodemographic factors.
Keywords: type 2 diabetes mellitus, T2DM, medication adherence, lifestyle adherence, self-
efficacy, health literacy, health locus of control
Introduction
According to the WHO, type 2 diabetes mellitus (T2DM) is a chronic disease caused 
by the body’s ineffective use of insulin.1 Treatment of T2DM requires complex life-
style therapy in addition to medication.2 This means that people with T2DM must 
control their blood glucose levels and concurrently keep their body weight and blood 
pressure at an optimum level, requiring dietary therapy as well as regular physical 
exercise.3 It is important to highlight that uncontrolled blood glucose levels can 
increase the risk of microvascular and macrovascular complications. Microvascular 
complications include retinopathy, nephropathy, and neuropathy, while macrovascular 
complications affect the large blood vessels and include cardiovascular diseases and 
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strokes.1,4 If the patient is required to take medication to 
lower blood glucose levels, this can only be effective if the 
patient also undergoes lifestyle therapy. It is important to 
note that personalized diabetes therapy is based on patients’ 
health condition.3
The importance of adherence
The therapy administered to people diagnosed with T2DM 
is usually designed to meet requirements and needs, with 
adherence (therapy loyalty) being of key importance.5 
Adherence behavior among people with diabetes generally 
lowers blood glucose levels and shows a higher correlation 
with self-efficacy, health literacy, and health locus of control 
(HLOC) of patients than with demographic variables.6,7 The 
underlying reasons for nonadherence among patients with 
diabetes should be examined in association with psychosocial 
factors, and it is also worth considering what led to lower 
adherence and what form it took.8
In the literature on the subject, the most often cited 
psychosocial factor for patient adherence is diabetes self-
efficacy,9,10 which determines coping behavior of individuals, 
the amount of effort they are capable of expending, and 
the amount of time they will face obstacles and adverse 
experiences.11 More precisely, self-efficacy means that 
people believe in their own abilities and feel that they 
have control over events around them.11 According to the 
research conducted by Indelicato et al in 2017, there is a 
significant correlation between the glycemic level of patients 
with diabetes and the level of confidence patients have in 
their own ability to exercise a positive effect on their own 
health status.9 Apart from this confidence, another often 
cited psychosocial factor for adherence is patients’ HLOC 
belief.12 In internal HLOC, individuals attribute their health 
to their own actions and they believe that health outcomes 
are under their control. In contrast, external HLOC beliefs 
include chance expectations or environmental circumstances 
and control by powerful others such as physician or family 
members.13 Further research findings indicate that there is 
a significant, positive correlation between the self-efficacy 
of individuals and their internal HLOC on the one hand and 
medication adherence on the other.10 Additionally, there 
are studies highlighting the importance of health literacy 
during diabetes adherence: “Health literacy is the degree to 
which individuals have the capacity to obtain, process, and 
understand basic health information and services needed to 
make appropriate health decisions.”14 Recent studies show 
a correlation between adherence and health literacy8,15–17 
and between patients’ HLOC17,18 and their health belief,19 
as adherence is determined by the amount of information 
they understand and internalize about the illness and the 
treatment.
There are various reasons for nonadherence behavior 
in patients with diabetes. Patients’ attitude can be affected 
by an inappropriate level of health literacy, fear of side 
effects of medication, or even the complexity of managing 
medication. Patient–physician communication is an impor-
tant factor in adherence; there is a significant, positive 
correlation between physician communication and patient 
adherence.20–22 Of course, patients must possess appropriate 
cognitive functions, memory, and ability to understand 
to follow doctor’s instructions, as well as personality and 
psychological resources that may contribute to coping with 
diabetes successfully.19 The importance of these variables 
and their relation to diabetic therapy and adherence are 
discussed below in great detail following a review of the 
types of adherence.
Various types of adherence in diabetic 
therapy
In the present study, we determine medication adherence 
(adherence-M), glucose monitoring adherence (adherence-
GM), dietary adherence (adherence-D), and physical exercise 
adherence (adherence-PE). It is currently becoming part of 
efficient and effective treatment to explore and understand 
the correlations between various types of adherence; it can 
be considered key to therapy success. Few studies examine 
the diverse types of adherence among T2DM patients, 
and most of these studies focus on the adherence-M.2,5,18,23 
This is probably due to the fact that this type of adherence 
is the easiest to examine and quantify, as, in addition to 
self-reporting, there are various objective measurements at 
our disposal to follow the drug regimen; furthermore, the 
majority of doctors place an emphasis on a pharmaceutical 
solution.4,18,23 However, diabetes requires lifelong profes-
sional care, and the key to preparing tertiary prevention 
regimens is to explore the correlation between additional 
adherences in depth and to understand them.24
According to Debussche, one of the key factors required 
for adherence is that patients must be able to make informed 
decisions on their own, possess good problem-solving skills, 
be able to manage their disease, and be open to cooperation 
with health care professionals, as this will enable them to 
achieve a higher quality of life.25 Adherent attitude toward 
diet can only be successful if the disease does not directly 
affect the person’s well-being; that is, the criteria for dietary 
therapy can be adapted to the lifestyle of the person. Eckert 
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underlined the point that for lifestyle therapies social con-
text and social support play a central role in the strategies 
the patient develops for coping with the disease, while the 
success of self-management depends more on the person’s 
self-efficacy. However, it should be pointed out that self-
efficacy develops parallel to successful adaptation and the 
development of coping strategies; it is not a result of the 
process. Eckert also stressed that based on studies con-
ducted on adherence-PE, people with T2DM over 63 years 
of age who exhibit adherence behavior regarding physical 
exercise incurred lower health care expenditures on antidia-
betics and other medication and required medical services 
less frequently.3 It is important to note that a high level of 
patient adherence to physical exercise therapy significantly 
improves blood glucose levels, as the blood supply to muscles 
improves, thus increasing the body’s glucose utilization.26 
Moreover, regular physical exercise helps maintain optimal 
body weight, boosts life satisfaction, improves lipid profile, 
and benefits mental health.27 In general, we can say that 
nonadherence behavior in relation to lifestyle therapy shows 
a significant inverse correlation with more severe complica-
tions in patients and their frequency.24
Adherence to self-monitoring of blood glucose poses 
a considerable challenge among diabetes patients, firstly, 
because it imposes restrictions on patient lifestyle, telling 
them when to eat, and it shows a strong correlation with 
adherence-D and adherence-PE. Secondly, if it is not appro-
priately regulated, it can cause frequent low blood glucose 
levels as well as increase the incidence of complications.28,29 
More precisely, since the therapy of patients with T2DM is 
determined by changes in HbA1c levels, adherence rate for 
glycemic monitoring is affected significantly by patients’ 
problem-solving skills as well as by the proper setting of 
treatment targets.30 In addition to these considerations, 
adherence to self-monitoring of blood glucose levels is 
closely associated with lifestyle therapies and can indeed be 
considered the key lifestyle therapy. This type of adherence 
is usually associated with a higher level of health literacy, 
including a sufficient amount of information about the illness. 
Indeed, how much patients can manage their own diabetes 
depends first and foremost on their knowledge of the self-
monitoring of blood glucose levels.31
Findings from previous studies indicate that it would be 
important to explore types of adherence one by one as well 
as to review factors affecting adherence in diabetes patients 
from perspectives that would shed light on the dynamics and 
modes of action of correlations. In the following sections, we 
explore the literature on the relationship of the psychosocial 
factors to adherence that presumably have a significant effect 
on the management of diabetes.
The importance of health literacy and its 
effect on adherence
Fransen et al collected and analyzed empirical studies on 
health literacy and patient self-management behaviors. They 
concluded that for diabetic therapy to be successful, it was 
necessary for patients not only to be motivated, but also to 
have great self-efficacy as well as high health literacy.32 This 
is because low health literacy in patients with diabetes may 
hinder their adherence behavior as they cannot comprehend 
and organize information effectively, thus potentially causing 
further difficulties with regard to following doctor’s orders.33 
These findings are confirmed by further studies, which have 
found that patients’ disease knowledge correlates with their 
perceived self-efficacy.15,34 A low level of health literacy has 
a negative effect on the health of the patients concerned;16,35 
moreover, patients’ disease knowledge has an influence on 
their therapy adherence rate.31,36,37 Based on a comprehensive 
meta-analysis and a review, the relationship between health 
literacy, adherence, and self-efficacy is inconsistent.34,38
The role of the locus-of-control belief in 
diabetic therapy
With chronic patients, in addition to adherence, the locus-
of-control belief can also be crucial for further improvement 
of health status.39 Internal control has a positive effect on 
the health behavior of the patient;40 it may influence which 
health-related behaviors a person will prefer or perform 
during diabetes therapy.41 However, a lack of internal control 
may lead to unhealthy dietary choices among people with 
diabetes.42 These points are also supported by the research 
conducted by Wallston and Wallston among patients diag-
nosed with chronic illnesses; they found that with regard 
to the dimensions of HLOC patients with a high level of 
both internal and external–social control exhibited a higher 
level of adherence among the medical staff.57 If we look at 
it from the diabetes patients’ perspective, it is probable that 
the high level of internal HLOC in conjunction with other 
psychosocial resources may improve the adherence behavior 
of patients toward the therapy.
Self-efficacy and its relationship to 
lifestyle therapy
As belief in one’s self-efficacy can bring about behavioral 
changes, it plays an important role among diabetes patients, 
particularly in managing the therapy.15 Patients with T2DM 
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who have more severe symptoms of depression and anxiety 
and experience greater stress tend to feel less efficient and 
committed to diabetic therapy.15,43 It has also previously 
been observed that lower self-efficacy in diabetes has a 
negative effect on the control of HbA1c level in patients15,44 
and shows a relationship with lower health literacy.43 As 
noted earlier, therapy for patients with diabetes requires 
lifestyle changes as well, so how much patients are able to 
face initial difficulties greatly depends on their level of self-
efficacy: patients with low self-efficacy tend to be stopped 
by the first obstacle and focus on the unfavorable outcome 
of their illness.45
Objectives
The objective of this study is to explore the adherence 
behavior of patients with T2DM by examining the associa-
tions between the various types of adherence: adherence-M, 
adherence-GM, adherence-D, and adherence-PE. More-
over, we would also like to test whether health literacy, 
self-efficacy, and HLOC belief affect therapy adherence. 
Additionally, we made first steps to explore patient-related 
barrier factors which hypothetically affect adherence during 
diabetes therapy.
Patients and methods
settings and sample
Study participants were patients diagnosed with T2DM 
receiving treatment at the Diabetes Unit, 1st Department 
of Internal Medicine, Szent-Györgyi Albert Health Centre, 
University of Szeged. The patients were in the process of 
switching from antidiabetics to insulin, or from one type 
of insulin to another. A diabetologist participated in the 
development of instruments. Data were collected between 
February and November 2016 by convenience sampling 
conducted by an interviewer who asked the participants to 
evaluate their adherence to diabetic therapy by filling out 
a questionnaire. The final sample consisted of responses 
from 113 patients, including 38 men and 75 women. The 
average age of the participants was 60.56 years (SD=12.9, 
minimum: 20 years, maximum: 85 years), and the partici-
pants were diagnosed with diabetes mellitus for an average 
of 13 years (SD=8.2). When the data were processed, one 
patient’s data had to be excluded as the person had been 
diagnosed with diabetes for 60 years, which was an outlier 
in our sample.
study measurements
The psychosocial parameters for adherence were measured 
using our own questions based on validated questionnaires, 
which contained certain items on HLOC belief, health 
belief, and perceived self-efficacy as well as some items on 
treatment methods and health literacy. In addition, we used 
an adherence questionnaire conceptualized by the research 
group to explore the different adherence types and collected 
participants’ demographic data (Table 1). Our question-
naire measures diverse types of adherence: adherence-M, 
adherence-GM, adherence-D, and adherence-PE. The section 
about adherence-M contains statements related to medication 
prescription and taking medication according to prescription. 
Adherence-GM, which means a consistent and regular blood 
glucose level monitoring, was measured with a statement 
related to prescribed treatment regimens. Lifestyle therapy 
adherences (adherence-D and adherence-PE) were measured 
with statements related to medical nutrition therapy and 
daily physical exercise (Figure S1).
The statements regarding adherence inhibitors were 
formulated specifically for the target group and were con-
sistent with study objectives. The adherence inhibitors 
included financial difficulties, forgetfulness, lack of time, 
family problems, disagreement with doctor’s instructions, the 
ineffectiveness/harmfulness of prescribed medical therapy 
according to other sources, fear of side effects and long-term 
effects, lack of clear instructions given by the doctor, lack of 
clear instructions in the product description of the medica-
tion, overly complicated/complex therapy, self-restraint to 
therapy, and lack of motivation to follow a regimen.
Multidimensional hlOc scale
The scale used for evaluating HLOC in this study was based 
on the validated questionnaire created by Wallston; however, 
Table 1 sociodemographic characteristics of the sample and 
descriptive statistics for the study variables
Sociodemographic factors N=113
sex  
Male, n (%) 38 (33.6)
Female, n (%) 75 (66.4)
Age (years), mean (sD), range 60.56 (12.9), 20–85
20–63 years old, n (%) 62 (54.9)
$63 years old, n (%) 51 (45.1)
Duration of diabetes (years), mean (sD) 13 (8.2)
labor market status  
employed, n (%) 33 (29.2)
retired, n (%) 80 (70.8)
education level  
low level, n (%) 60 (53.1)
high level, n (%) 53 (46.9)
Note: sociodemographic characteristics of the sample show normal distributions.
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unlike the original, it contained diabetes-specific statements 
to assess patients, and also had fewer questions. One state-
ment about internal HLOC belief was “Diabetes basically 
depends on your own self-strength”, while a statement “In the 
treatment of diabetes, the social environment (physician, 
family, friends) is extremely important” was an item present 
on the strong social–external HLOC subscale. Furthermore, 
external HLOC belief was measured with statements like 
“The improvement or decline of health condition related 
to diabetes is mostly random”. The internal consistency 
value on the internal HLOC scale proved to be acceptable, 
while with the social–external and chance external HLOC 
the small number of items meant that no relevant reliability 
could be measured.
health belief scale
According to the literature, one of the most widespread 
models of health behavior is the health belief model. A pri-
mary objective of the model is to predict the factors that 
determine health behavior, mainly through participation in 
screening examinations. Health behavior is primarily influ-
enced by perceived danger, which is a combination of the 
severity of a perceived illness or the consequence of failing 
to take preventive measures to prevent illness and an estimate 
of the degree to which a person feels affected by it. Other 
components of the model are the benefits the behavior can 
bring as well as the obstacles, costs, and disadvantages of 
the behavior. In addition to the health-related beliefs factor, 
the model contains a perceived efficacy variable, as in “You 
are able to effectively treat your illness and its symptoms, 
to cope with the illness and to comply with the treatment 
requirements”. The internal reliability index for the health 
belief factor on the questionnaire was 0.651, while the 
internal consistency for self-efficacy amounted to a somewhat 
lower value due to the small number of items.
Data analysis
Statistical analysis of the data was performed using IBM 
SPSS for Windows 22 (IBM Corporation, Armonk, NY, 
USA). The first step was to prepare statistical data, so we 
detected missing values and screened the outliers. Before 
selecting the trial, it is important to know whether we can 
perform a parametric test or not. While processing the 
data, we checked the distributions of participants’ sociode-
mographic data and statistics by analyzing their scores 
(mean ± SD) (Table 1). We checked normality by item, ques-
tionnaire, and group to select the relevant statistical hypoth-
esis tests. Since the Kolmogorov–Smirnov hypothesis testing 
procedure showed that the conditions for normality deviation 
were not always met, we decided to use nonparametric tests. 
As we wanted to measure the effect of several independent 
variables, a multivariate regression analysis was performed. 
In addition, we decided to use the stepwise method, which is 
one of the most stringent methods. We paid careful attention 
to the fact that multivariate regression analysis is extremely 
sensitive to outliers. In order to get more reliable results, we 
standardized the variables. With this in mind, we decided 
to use nonparametric tests. We also agreed that the statisti-
cally significant P-value should be ,0.05. We examined the 
associations between variables using Spearman’s rank cor-
relation and used multivariate regression analysis to identify 
predictive variables for adherent behavior. As mentioned 
before, the variables were standardized and we used these 
in all our measurements (Spearman’s rank correlation, mul-
tivariate regression analysis). In addition, we attempted to 
examine factors with a negative effect on adherence using 
factor analysis.
We performed an exploratory factor analysis for adher-
ence inhibitors to identify items that measure similar phe-
nomena and content. The exploratory factor analysis was 
performed using the principal component analysis method 
with oblimin rotation. The applicability of data for factor 
analysis was tested using Bartlett’s test of sphericity as well 
as the Kaiser–Meyer–Olkin index. In addition, variables with 
a factor loading ,0.3 were not considered.
Results
The final sample consisted of 113 T2DM inpatients with a 
mean age of 60.56 years (SD=12.94, range: 20–85 years) and 
an average diabetes duration of 13 years. On the Diabetes 
Adherence Questionnaire, 87.6% of the respondents stated 
that they get all the prescribed medicines, and 80.5% of 
respondents reported taking medications according to 
prescriptions. Furthermore, 78.8% of the patients stated 
being adherent to measuring blood glucose level, while 
adherence to diet was stated by only 13.3% of respondents. 
Moreover, only 12.4% of respondents reported adherence to 
physical exercise. Table 2 shows the different frequencies 
of responses as not all participants were willing to provide 
response to each item. In the case of items about psychosocial 
variables, the majority of responses indicated a high level of 
adherence (Table 3).
examining the association between the 
various types of adherence
Adherence-M showed a positive, significant correlation 
with adherence-GM among patients (r=0.322, P,0.001); 
that is, the patients are more adherent to drug treatment, 
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the more likely they are to follow doctor’s orders on the 
self-monitoring of glucose levels. However, adherence-M 
showed a moderate-to-negative correlation with patients’ 
adherence-D (r=-0.575, P,0.001). This finding suggests 
that the more patients adhere to taking antidiabetics regu-
larly and properly, the less motivated they feel to adhere 
to carbohydrate intake and to meet the criteria for a proper 
diet. Furthermore, we found a moderate, significant, and 
inverse correlation between adherence-M and adherence-
PE (r=-0.496, P,0.001), suggesting that the more patients 
follow medication orders, the less they will adhere to 
physical exercise therapy. Adherence-D showed a correla-
tion with adherence-GM (r=0.414, P,0.001) as well as with 
adherence-PE (r=0.279, P=0.003). Based on these findings, 
we can say that the evaluated subjects attempted to integrate 
the diet prescribed for people with diabetes, were more 
likely to control their blood glucose levels, and found time 
to follow the prescribed physical exercise regimen (Table 4).
Association of lifestyle, glucose 
monitoring, and medication adherence 
with psychosocial variables
As emphasized in the “Introduction” section, T2DM requires 
a complex therapy, in which lifestyle plays a key role, so we 
thought it is imperative to examine in greater detail the factors 
that influence adherence-D and adherence-PE. When devel-
oping the linear regression model for adherence-D, we found 
that the model is significant (F (2.81)=8.466, MSE =0.887, 
P,0.001); its explanatory power for the whole range was 
17.3%. The independent variables were the following: 
duration of diagnosed diabetes, age, education level, self-effi-
cacy, health literacy, internal HLOC belief, social–external 
HLOC belief, and external HLOC belief. Adherence-D 
was predicted by patient self-efficacy (β=0.366, t
81
=3.622, 
P=0.001) and the duration of diagnosed diabetes (β=0.208, 
t
81
=2.062, P=0.042). The data on adherence-PE proved insuf-
ficient to set up the linear model due to the disproportionate 
number of responses given to a particular statement.
Adherence-GM showed a significant, positive correlation 
with patients’ internal HLOC belief (r=0.380, P,0.001) as 
well as the number of antidiabetics taken daily (r=0.211, 
P=0.049). The linear regression model used proved significant 
(F (3.78)=10.077, MSE =0.744, P,0.001); its explanatory 
power for the entire range was 27.9%. The independent vari-
ables were the following: duration of diagnosed diabetes, age, 
education level, self-efficacy, health literacy, internal HLOC 
belief, social–external HLOC belief, and external HLOC 
belief. Of the variables measured, social–external HLOC 
Table 2 response rate for the diverse types of adherence
Type of evaluated adherence Questions Percentage of adherent responses
Medication adherence getting all the prescribed medicine 87.6%
Take medication according to the prescription 80.5%
glucose monitoring adherence Measuring blood glucose level 78.8%
Dietary adherence Medical nutrition therapy 13.3%
Physical exercise adherence Daily physical exercise 12.4%
Notes: The table shows the items of different types of adherence based on the Diabetes Adherence Questionnaire. it is important to note that only values 4 and 5 on the 
5-degree likert-scale were interpreted as adherent responses.
Table 3 Response rate for perceived self-efficacy, health literacy, and HLOC belief
Type of evaluated 
phenomenon
Questions Percentage of 
“agree” responses
health literacy You are perfectly informed about your illness and its healing and treatment. 76.9%
You are perfectly able to apply the prescribed treatment for your illness. 75.2%
Self-efficacy Following the prescribed treatment regimens for my illness is efficient in treating its 
symptoms and effectively improve my health status.
83.2%
You are able to effectively treat your illness and its symptoms, to cope with the illness, and to 
comply with the treatment requirements.
76.1%
health locus of control Diabetes basically depends on your own self-strength. 84.1%
in the treatment of diabetes, the social environment (physician, family, and friends) is 
extremely important.
80.5%
The improvement or decline of health condition related to diabetes is mostly random. 26.6%
Notes: The table shows the items of self-efficacy, health literacy, and HLOC belief based on the Diabetes Adherence Questionnaire. It is important to note that only values 
4 and 5 on the 5-degree likert-scale were interpreted as adherent responses.
Abbreviation: hlOc, health locus of control.
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(β=0.312, t
78
=2.941, P=0.004), perceived self-efficacy 
(β=0.241, t
78
=2.484, P=0.015), and internal HLOC were found 
to be the strongest predictors of adherence-GM (Figure 1).
results from the factor analysis of 
adherence inhibitors
Based on our results, we identified five factors. In accordance 
with statistical standards, we discuss the “doubts about 
therapy” and “cognitive skills” factors at length below.
The “doubts about therapy” factor contained items that 
may have caused adherence inhibition, such as sacrifices, the 
complexity of therapy, and fear of side effects. The internal 
consistency of the “doubts about therapy” factor was 0.672, 
which indicates an acceptable reliability.
The “cognitive skills” factor contained all those variables 
inhibiting adherence linked to medication instructions pro-
vided with the product and agreement with doctor’s orders. 
The internal consistency of “cognitive skills” turned out to 
be 0.731, which indicates high reliability (Figure 2).
Having obtained all these results, we also checked 
whether the factors with high internal reliability showed 
any correlation with the various types of adherence. After 
performing the statistical analyses, we found that there was 
a significant negative correlation between the “doubts about 
therapy” factor and adherence-D (r=-0.368, P=0.001).
Discussion
The objective of our study was to explore the adherence 
behavior of patients with T2DM, mainly by ascertaining the 
association between the diverse types of adherence and their 
determining psychosocial factors. Since previous studies 
have focused primarily on adherence-M,2,5,21,28 we believe the 
advantage of our study is that we considered the complex-
ity of variables (the diverse types of adherence and health 
literacy, self-efficacy, and HLOC belief affecting them) 
and that we focused mainly on determining the associations 
between them.
Under examination, we found that there was a moderate, 
significant, and inverse correlation between adherence-M 
and lifestyle factors. More specifically, the more patients 
adhere to taking medication as prescribed, the less likely 
they were to adhere to dietary therapy and physical exercise. 
The unexpected finding that higher adherence-M correlates 
to significantly lower adherence-D and adherence-PE is 
explained in a number of studies by the fact that in an early 
phase of the disease patients can avoid hyperglycemia by 
taking medication that reduces blood glucose.3,16,18 However, 
this is only a temporary solution, and patients with diabetes 
must follow a special diet and start doing physical exercise, 
as the dose–response curve of the medication used cannot 
offset the blood glucose increase caused by absorption of 
carbohydrates from food.
In our study, adherence-GM showed a significant, 
positive correlation with adherence-M and adherence-D. 
These findings are consistent with observations found in the 
literature.29,46,47 If adherence-GM is to be considered as one of 
the main means of diabetic therapy, which can help recognize 
and prevent hypoglycemia and avert metabolic crises, then it 
would also be imperative to examine what may cause inap-
propriate glucose tests in future. The underlying reasons for 
the study findings can probably be traced back to patients not 
following dietary instructions closely, as the data collection 
Figure 1 Psychosocial variables predicting glucose monitoring adherence indicated 
with beta values.
Notes: The multivariate regression analysis showed that adherence-gM was mostly 
predicted by self-efficacy, internal HLOC belief, and social–external HLOC belief. 
The numbers show beta values or coefficients which show the degree of change in 
the outcome variable for every one unit of change in the predictor variable. *P,0.05.
Abbreviations: Adherence-gM, glucose monitoring adherence; hlOc, health 
locus of control.
???????????????????
?????????????????? ????????????????
????????????????????????????????? ????????????????????????????????????????
Table 4 The relationship between various adherence types and spearman’s rank correlation values
Group Adherence-M Adherence-GM Adherence-D Adherence-PE
Adherence-M  0.322* -0.575** -0.496**
Adherence-gM 0.322*  0.414**  
Adherence-D -0.575** 0.414**  0.279*
Adherence-Pe -0.496**  0.279*  
Notes: *P,0.05; **P,0.01.
Abbreviations: Adherence-M, medication adherence; Adherence-gM, glucose monitoring adherence; Adherence-D, dietary adherence; Adherence-Pe, physical exercise 
adherence.
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was supervised by a medical professional. This is confirmed 
by the fact that since the participating patients were in the 
process of switching to insulin, it was reasonable to change 
therapies because the various types of diabetic therapy did 
not provide them with the metabolic status they wanted to 
achieve. Overall, if we only attempt to draw conclusions 
from the perspective of various adherences, we can say that 
keeping glucose levels within an optimal range takes more 
than just medication; patients’ carbohydrate intake and 
dietary habits are also crucial.
Based on our findings, we can say that the degree of 
adherence-D does not only correlate with adherence-GM, 
but shows a significant correlation with adherence-PE as 
well. Thus, if patients can tell the difference between their 
blood glucose conditions and can regulate their blood glucose 
levels accordingly, they are more likely to pay attention to 
what they eat and make sure they lead a healthy lifestyle. 
We believe the underlying reason for this is that appropriately 
educated patients are aware of the fact that their body will 
initiate insulin secretion with some delay after the ingestion 
of food and that blood glucose levels may shoot up as a result, 
so adherence to dietary therapy may become crucial. When 
we look at the association of adherence-D to other types 
of adherence, we must keep in mind that these processes 
are also affected by how much patients are able to resolve 
problematic situations, that is, how resourceful they are, as 
well as how advanced their diabetes is.
The findings of the study demonstrated the lowest 
response rate among lifestyle adherences for adherence-PE. 
A potential reason for this is that it is often unclear even to 
health care professionals what is meant by physical exercise 
therapy, as it is not clearly defined.48 Our findings suggest 
that adherence-PE was in inverse correlation with the degree 
of adherence-M. In interpreting the findings, it should be 
noted that we examined results for elderly diabetes patients 
for the most part. The reason for low adherence-PE may be 
that long-running medication therapy for the patients in the 
sample was sufficient to control blood glucose levels, sug-
gesting that they had had decades-long lifestyle habits that 
could only be changed with sufficient motivation, effort, and 
determination.7 Having discussed the correlations between 
the various adherences, let us now focus on an understand-
ing of the effects the presumed psychosocial factors exer-
cise on adherences. In a number of studies, adherence-D 
shows a positive correlation with patient self-efficacy, 
internal and external professional HLOC belief, and health 
literacy.8,15,33,34,39,41,44 Our results are consistent with these find-
ings in confirming that internal HLOC plays an important role 
in dietary therapy adherence. Where our findings differ from 
the literature is the effect of external HLOC on the degree 
of dietary adherence. We attempt to explain the unexpected 
findings by drawing on an assertion in the literature: in the 
period of switching from one therapy to another, patients 
may have felt lower motivation and internal control due to 
previous failures, an experience which is even greater among 
the elderly as they may have other comorbidities beyond 
diabetes that render their everyday life difficult.44,46 Closely 
related to this is the finding that patients who are exposed 
Figure 2 The factor structure of adherence inhibitors.
Notes: The path diagram of exploratory factor analysis displays the final model. The numbers show standardized factor loadings, and the items related to the factors “doubts 
about therapy” and “cognitive skills”. The numbers attached to each item within each rectangular box indicate the item numbers in the adherence inhibitors scale. *P,0.05.
0.672*
0.819*
11. Self-restraint related to therapy
10. The therapy is too complicated/complex
5. Disagreement with doctor’s instructions
8. Lack of clear instructions given by the
doctor
9. Lack of clear instructions in the product
description of the medication
6. The ineffectiveness/harmfulness of
prescribed medical therapy according to
other sources
0.739*
0.654*
0.822*
0.754*
0.560*
0.731*
Adherence
inhibitors
Doubts about
therapy
Cognitive skills
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to excessive stress and exhaustion generally score lower 
on health literacy scales.49 However, it seems productive to 
explore the link between health literacy and beliefs about the 
harmfulness of treatment.38
In addition to these tests, we also wished to ascertain 
which psychosocial factors measured would be the best pre-
dictors of adherence-D. Our findings showed that there was 
a 17.3% correlation between adherence-D and the patient’s 
perceived self-efficacy and the years of diagnosed diabetes. 
Furthermore, these are the variables that best predict a 
patient’s adherence. The results can be explained by a fact 
familiar to us through the literature that self-efficacy is a self-
regulation skill which suggests a belief in oneself being able 
to overcome difficulties and as such can only be achieved 
through a learning process. This means that patients with 
diabetes generally do not begin dietary therapy overnight, 
but face difficulties at the beginning, set their minds to it, 
and exercise strict self-control.
Adherence-GM shows the most significant, positive 
correlation with patient health literacy and internal HLOC. 
Our findings confirmed that adherence-GM among patients 
with diabetes shows a correlation with internal HLOC as 
well as the number of antidiabetic pills taken every day. 
In other words, the better patients are at keeping their HbA1c 
levels within the normal range, the more likely they are to 
have HLOC and the more antidiabetics they will take every 
day.5,8,50 If we explain the findings by saying that the number 
of pills in this case simply reflects the degree of adherence-M, 
then it means that HLOC belief is a key to effective medica-
tion therapy. However, it is important to note that we also 
ascribed a key role to health literacy in connection with 
this type of adherence in our study; however, no significant 
correlation could be shown between the two variables. Any 
result that differs from what we expect should be considered 
carefully, as it may be assumed that the items on health 
literacy did not test for all the health literacy skills. The latter 
confirms that the knowledge patients possess about their 
health is formulated through very complex processes, and 
this underlines the complexity of the phenomenon.30
In addition to the psychosocial factors affecting 
adherence-GM, we also set up a linear model to measure 
which psychological and psychosocial factors most predict 
a higher degree of patient adherence. Our findings suggest 
that adherence-GM was 27.9% depending on the personality 
traits of the patients. More specifically, of the personality 
factors measured, it was social–external HLOC that pre-
dicted adherence-GM, while diabetes self-efficacy was 
most accurately predicted by internal HLOC. According 
to Krapek et al,7 adherence increases when blood glucose 
level is adequately regulated. Furthermore, if we make a 
comparison based on this finding, we can say that patients 
with high self-efficacy can affect their health status better, 
an assertion which is consistent with the theoretical concept 
that perceived control and a feeling of self-efficacy reduce 
stress and help cope with the disease.
In addition, the relationship between adherence and self-
efficacy plays an important role not only in adherence-M, 
but also in adherence-GM.9,10,15 Indeed, in order to regulate 
blood glucose levels, it is necessary for patients to experience 
a sense of effectiveness and be able to make independent 
decisions that comply with the doctor’s orders with regard 
to the self-management of diabetes.
Our statements on health literacy, which consist of infor-
mation on methods of treatment for the disease, showed a 
correlation with the types of adherence measured. We found 
that a significant, positive correlation can be seen between 
adherence-D and items on knowing appropriate methods of 
the treatment. Furthermore, we found that the diverse types 
of adherence can be affected by perceived self-efficacy. 
We can thus assume that those who can maintain their 
metabolic state and regulate their blood glucose levels tend 
to follow recommendations on diet and believe that they 
can manage their illness. In our research project, we also 
grouped factors that inhibit adherence, and we concluded 
that the factors that trigger nonadherence include doubts 
about therapy and the person’s cognitive skills. Since it is 
difficult to explore factors inhibiting adherence due to the 
complexity of the phenomenon and it therefore requires 
additional investigation, the findings should be handled 
with caution.
The “doubts about therapy” factor refers to adherence 
inhibitors from the perspective of socioeconomic factors and 
factors that depend on therapeutic treatment, such as self-
restraint in connection with therapy, complexity of therapy, 
and fear of side effects. Variables inhibiting adherence that 
fall within this factor are not often discussed in the literature, 
since it tends to vary from one person to another among 
those with diabetes as to what they see as sacrifice and what 
personal fears they have as regards diabetic therapy. How-
ever, the complexity of therapy is considered an inhibiting 
factor that determines the adherence behavior of patients. 
This finding is consistent with that of Donnan et al18 and 
Rubin28 that the complexity of diabetic therapy may decrease 
patient adherence by as much as 10%–20%. This result is in 
line with those of our investigation into adherence-M and 
lifestyle therapy.
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The “cognitive skills” factor differs from the factors 
above in that the patient’s health status and attitudes play a 
more marked role. Disagreeing with doctor’s orders is often 
accompanied by lower health literacy, a tendency which is 
linked to patients not clearly grasping what the doctor has 
told them or not being able to adequately understand med-
ication instructions provided with the product. Furthermore, it 
should be noted that doctors and health professionals tend to 
overrate patients’ cognitive skills, adherence, and knowledge 
about the therapy,17,51,52 thus rendering it more difficult to 
recognize adherence inhibitors in a timely manner.
A key point in our exploratory research project was that 
once we had collected adherence inhibitors and analyzed 
their nature and characteristics, we also examined which 
of the diverse types of adherence showed a statistically 
significant correlation. We found that among the adherence 
inhibitors, “doubts about therapy” demonstrated a significant, 
inverse correlation with adherence-D, suggesting that of 
the types of adherence, following dietary recommendations 
depended greatly on how complex and complicated the diet 
seems to the patient and how much the dietary therapy fits 
into the lifestyle the person has led thus far.
To our knowledge, our investigation of adherence inhibi-
tors is among the few that have used quantitative methods. 
Most studies examining this topic are qualitative.53–55 The 
literature to date has attempted to explore phenomena affect-
ing adherence behavior mainly along the lines of the doctor–
patient relationship and the characteristics of the health care 
system, even though factors affecting patient adherence also 
include information on the patient’s health status, patient-
dependent factors, and financial considerations.25 As noted 
above, this study mainly reviews results from elderly patients 
with diabetes. With this in mind, it is worth considering that 
a study conducted in 11 European countries with a sample 
of people aged above 70 years with diabetes found that 
good communication with the doctor and health care staff 
was key to adherence behavior. In such situations, it is not 
only possible for patients to ask their doctors, questions, but 
also to obtain answers and solutions for the dilemmas they 
face, thus possibly allaying the fears they may have about 
the side effects.56
limitations and future directions
Since this work was an exploratory research where we used 
the questionnaire compiled by ourselves, it would be advis-
able to increase the size of the sample and check the validity 
of our conclusions on a larger patient population. Another 
limitation is that the sample consisted of inpatients who were 
undergoing insulin replacement. Hence, it would be worthy 
to perform this study on T2DM outpatients who are not 
involved in a therapeutic regime change. A third limitation is 
that this research is self-explanatory; thus, social compliance 
may have an effect on the results obtained.
Overall, the current study can be considered innovative 
among scientific surveys of adherence, as to the best of our 
knowledge relatively few studies have dealt with correlations 
between adherences with such heterogeneous syndromes as 
T2DM. This claim is confirmed by the fact that to date no 
internationally validated measurement tool has been designed 
to explore the various types of adherence. Although we relied 
on the scientific literature in our study to design the models to 
be used to examine the phenomena, it would be worthwhile 
to develop these concepts further and investigate them in 
greater depth in future. This is linked to our aspiration for 
this study to serve as a starting point for developing future 
Hungarian standards, to set down a precise description of 
the psychosocial factors in adherence behavior and to design 
complex therapy programs that rely both on adherence-M and 
on dietary therapy and physical exercise therapy.
Conclusion
Thus, the study recommends to measure and understand 
diverse types of adherence of T2DM patients. The results 
of the current study also show that there are associations 
between diverse types of adherence and patients’ psycho-
social attributes.
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How much do you agree with the following statements? I follow
the prescribed treatment regimens for my illness with regard to:
(1 – strongly disagree, 5 – strongly agree)
Measuring different types of adherence:
Self-efficacy, health literacy, health locus of control:
How much do you agree with the following statements?
Please evaluate the following questions from 1 to 5.
(1 – strongly disagree, 5 – strongly agree)
1 - 2 - 3 - 4 - 51. You are perfectly informed about your
illness and its healing and treatment.
1 - 2 - 3 - 4 - 52. You are perfectly able to apply the
prescribed treatment for your illness.
1 - 2 - 3 - 4 - 53. Following the prescribed treatment
regimens for my illness is efficient in treating
its symptoms and effectively improve my
health status. 
1 - 2 - 3 - 4 - 54. You are able to effectively treat your
 illness and its symptoms, to cope with the
 illness, and to comply with the treatment
 requirements.
1 - 2 - 3 - 4 - 55. Diabetes basically depends on your own
self-strength.
1 - 2 - 3 - 4 - 56. In the treatment of diabetes, the social
environment (physician, family, and friends)
is extremely important.
1 - 2 - 3 - 4 - 57. The improvement or decline of health
condition related to diabetes is mostly
random.                  
1. Getting all the prescribed medicine.
2. Take medication according to the
prescription.
3. Measuring blood glucose level.
4. Medical nutrition therapy.
5. Daily physical exercise.
1 - 2 - 3 - 4 - 5
1 - 2 - 3 - 4 - 5
1 - 2 - 3 - 4 - 5
1 - 2 - 3 - 4 - 5
1 - 2 - 3 - 4 - 5
Adherence inhibitors:
If you do not follow a particular prescribed treatment,
which of the below-listed reasons do you attribute it to?
1. Financial difficulties 1 - 2 - 3 - 4 - 5
2. Forgetfulness 1 - 2 - 3 - 4 - 5
3. Lack of time 1 - 2 - 3 - 4 - 5
4. Family problems 1 - 2 - 3 - 4 - 5
5. Disagreement with doctor’s instructions 1 - 2 - 3 - 4 - 5
6. The ineffectiveness/harmfulness of
prescribed medical therapy according to
other sources 
1 - 2 - 3 - 4 - 5
7. Fear of side effects 1 - 2 - 3 - 4 - 5
8. Lack of clear instructions given by the
doctor 
1 - 2 - 3 - 4 - 5
9. Lack of clear instructions in the product
description of the medication
1 - 2 - 3 - 4 - 5
10. Overly complicated/complex therapy 1 - 2 - 3 - 4 - 5
11. Self-restraint related to therapy 1 - 2 - 3 - 4 - 5
12. Lack of motivation to follow a regimen 1 - 2 - 3 - 4 - 5
(1 – strongly disagree, 5 – strongly agree)
Figure S1 Diabetes Adherence Questionnaire.
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